IL-25 has been reported to be highly expressed in several skin inflammatory diseases, including atopic dermatitis (117), psoriasis (118), pyoderma gangrenosum (119), acute generalized exanthematous pustulosis (119), and cutaneous T-cell lymphoma (CTCL) (120). Here, IL25 is linked to primary cutaneous T-cell non-Hodgkin lymphoma.